Evidence map›Paper›PMID 40519662›Full record

ArticleCase reports in women's health2025

A case report with pathological insights into cotyledonoid dissecting leiomyoma: Essential for differentiating this rare benign tumor from cancer.

Masoud Edalati, Karam Khouri, Ahmed Lazim, Shuanzeng Wei, Anjali Seth, Daniela Proca

Abstract readCase Reports
In one paragraph

Article in Case reports in women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Masoud EdalatiDepartment of Pathology, Temple University Health System, Philadelphia, USA.
Karam KhouriDepartment of Pathology, Temple University Health System, Philadelphia, USA.
Ahmed LazimDepartment of Pathology, University of Pennsylvania, Philadelphia, USA.
Shuanzeng WeiDepartment of Pathology, Fox Chase Cancer Center, Philadelphia, USA.
Anjali SethDepartment of Pathology, Temple University Health System, Philadelphia, USA.
Daniela ProcaDepartment of Pathology, Temple University Health System, Philadelphia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cotyledonoid dissecting leiomyoma (CDL), also known as Sternberg tumor, is a rare uterine leiomyoma variant with distinct imaging, gross, and microscopic features that deviate from classic leiomyomas. Despite its benign nature, CDL frequently mimics malignancy on radiologic and clinical evaluations, posing a diagnostic challenge. Understanding its unique characteristics is crucial for correct diagnosis to prevent unnecessary aggressive treatment. This report concerns the case of a 52-year-old postmenopausal woman with abnormal bleeding and an enlarged uterus. Ultrasound revealed a 4.3 × 3.5 × 3.5 cm complex echogenic mass of undetermined etiology in the right adnexa. MRI demonstrated a heterogeneously enhancing, irregular mass between the right ovary and uterine fundus. Given her postmenopausal status, a total hysterectomy with bilateral salpingo-oophorectomy was performed. Gross examination revealed a red, spongy, nodular, and cystic tumor containing gelatinous material. The mass involved the right lateral uterine wall, extending toward the fundus and round ligament, but remained distinct from the ovary and fallopian tube. Microscopically, interlacing smooth muscle fascicles whorled around prominent thick-walled vessels, confirming the diagnosis of CDL-a rare, benign uterine leiomyoma with a unique gross and microscopic appearance. Recognizing CDL is critical for both clinicians and pathologists to avoid misdiagnosing it as malignancy. Increased awareness can prevent unnecessary radical treatment, ensuring appropriate patient management while avoiding potential overtreatment and associated complications.

Indexed as

Cotyledonoid dissecting leiomyomaCytogenomic microarray analysisMRINext-generation sequencing

Identifiers

PMID40519662
PMCPMC12163156

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.